Comparative Study
doi: 10.1176/ajp.135.12.1539.
Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate
- PMID: 717574
- DOI: 10.1176/ajp.135.12.1539
Item in Clipboard
Comparative Study
Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate
Am J Psychiatry.
1978 Dec.
Abstract
Forty-nine schizophrenic outpatients stabilized on oral antipsychotic medication and procyclidine received 12.5 mg or 18.75 mg of fluphenazine enanthate or fluphenazine decanoate and were examined for extrapyramidal side effects one and two weeks later. Extrapyramidal side effects were present in 30 patients (61%) but were clinically significant in only 11 (22%). Fluphenazine enanthate produced more clinically significant extrapyramidal symptoms, particularly akathisia, than did fluphenazine decanoate.
Similar articles
-
Antiparkinsonian agents and fluphenazine decanoate.Am J Psychiatry. 1976 Jan;133(1):80-2. doi: 10.1176/ajp.133.1.80. Am J Psychiatry. 1976. PMID: 1247126
-
Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.Am J Psychiatry. 1982 Mar;139(3):312-8. doi: 10.1176/ajp.139.3.312. Am J Psychiatry. 1982. PMID: 6120655 Clinical Trial. No abstract available.
-
Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.Neuropsychobiology. 1978;4(6):360-5. doi: 10.1159/000117652. Neuropsychobiology. 1978. PMID: 692838 Clinical Trial.
-
Side effects of depot fluphenazines.Adv Biochem Psychopharmacol. 1974;9(0):301-9. Adv Biochem Psychopharmacol. 1974. PMID: 4599435 Review. No abstract available.
-
The depot fluphenazines: a reappraisal after 10 years' clinical experience.Am J Psychiatry. 1975 May;132(5):491-500. doi: 10.1176/ajp.132.5.491. Am J Psychiatry. 1975. PMID: 1091162 Review. No abstract available.
Cited by
-
Past and present progress in the pharmacologic treatment of schizophrenia.J Clin Psychiatry. 2010 Sep;71(9):1115-24. doi: 10.4088/JCP.10r06264yel. J Clin Psychiatry. 2010. PMID: 20923620 Free PMC article. Review.
-
Drug-induced akathisia: a review.J R Soc Med. 1985 Sep;78(9):748-52. doi: 10.1177/014107688507800910. J R Soc Med. 1985. PMID: 2864445 Free PMC article. Review. No abstract available.
-
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.Psychopharmacology (Berl). 1985;87(1):30-3. doi: 10.1007/BF00431773. Psychopharmacology (Berl). 1985. PMID: 3933035 Clinical Trial.
-
Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
